TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
6,436,916
Share change
+130,170
Total reported value
$28,140,000
Price per share
$4.38
Number of holders
30
Value change
+$540,922
Number of buys
12
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q1 2015

As of 31 Mar 2015, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,436,916 shares. The largest 10 holders included Clarus Ventures, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., First Washington CORP, EMERALD ADVISERS INC/PA, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Point72 Asset Management, L.P., First Eagle Investment Management, LLC, Iguana Healthcare Management, LLC, and Alyeska Investment Group, L.P.. This page lists 30 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.